Share Price & News
How has Amrutanjan Health Care's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 590006 has not had significant price volatility in the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: 590006 underperformed the Indian Pharmaceuticals industry which returned 42.7% over the past year.
Return vs Market: 590006 underperformed the Indian Market which returned -1.4% over the past year.
Price Volatility Vs. Market
How volatile is Amrutanjan Health Care's share price compared to the market and industry in the last 5 years?
Simply Wall St News
Is Amrutanjan Health Care undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 590006 (₹408.65) is trading above our estimate of fair value (₹79.49)
Significantly Below Fair Value: 590006 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 590006 is poor value based on its PE Ratio (37x) compared to the IN Pharmaceuticals industry average (22.7x).
PE vs Market: 590006 is poor value based on its PE Ratio (37x) compared to the Indian market (16.1x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 590006's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 590006 is overvalued based on its PB Ratio (7.5x) compared to the IN Pharmaceuticals industry average (2.2x).
How is Amrutanjan Health Care forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Amrutanjan Health Care has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Check out Amrutanjan Health Care's track record over time to understand how much the company has returned to shareholders and its earnings growth rate in the past.
- Amrutanjan Health Care competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Pharmaceuticals & Biotech industry.
How has Amrutanjan Health Care performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 590006 has high quality earnings.
Growing Profit Margin: 590006's current net profit margins (12.2%) are higher than last year (9.8%).
Past Earnings Growth Analysis
Earnings Trend: 590006's earnings have grown by 12.5% per year over the past 5 years.
Accelerating Growth: 590006's earnings growth over the past year (25.3%) exceeds its 5-year average (12.5% per year).
Earnings vs Industry: 590006 earnings growth over the past year (25.3%) exceeded the Pharmaceuticals industry 14.7%.
Return on Equity
High ROE: 590006's Return on Equity (20.2%) is considered high.
How is Amrutanjan Health Care's financial position?
Financial Position Analysis
Short Term Liabilities: 590006's short term assets (₹1.3B) exceed its short term liabilities (₹390.6M).
Long Term Liabilities: 590006's short term assets (₹1.3B) exceed its long term liabilities (₹68.6M).
Debt to Equity History and Analysis
Debt Level: 590006 is debt free.
Reducing Debt: 590006 has no debt compared to 5 years ago when its debt to equity ratio was 2.5%.
Debt Coverage: 590006 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 590006 has no debt, therefore coverage of interest payments is not a concern.
What is Amrutanjan Health Care current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 590006's dividend (0.27%) isn’t notable compared to the bottom 25% of dividend payers in the Indian market (0.56%).
High Dividend: 590006's dividend (0.27%) is low compared to the top 25% of dividend payers in the Indian market (2.31%).
Stability and Growth of Payments
Stable Dividend: 590006's dividend payments have been volatile in the past 10 years.
Growing Dividend: 590006's dividend payments have fallen over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its low payout ratio (10%), 590006's dividend payments are thoroughly covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Sambhu Sivalenka (46 yo)
Mr. Sambhu Prasad Sivalenka, B.Tech (USA), M.B.A. (USA) has been the Managing Director of Amrutanjan Health Care Limited and serves as its Chairman since February 13, 2012. He has been Director of Amrutan ...
CEO Compensation Analysis
Compensation vs Market: Sambhu's total compensation ($USD171.96K) is below average for companies of similar size in the Indian market ($USD316.35K).
Compensation vs Earnings: Sambhu's compensation has been consistent with company performance over the past year.
|Chairman & MD||no data||₹12.76m||18.78% |
|Non-Executive Director||31.17yrs||₹420.00k||8.71% |
|Non-Executive & Independent Director||17.25yrs||₹680.00k||no data|
|Non-Executive Independent Director||5.42yrs||₹820.00k||0.0017% |
|Non-Executive Independent Director||6.08yrs||₹540.00k||no data|
|Non-Executive & Independent Director||8.92yrs||₹440.00k||no data|
|Non-Executive Independent Director||5.42yrs||₹850.00k||0.076% |
Experienced Board: 590006's board of directors are considered experienced (8.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Amrutanjan Health Care Limited's company bio, employee growth, exchange listings and data sources
- Name: Amrutanjan Health Care Limited
- Ticker: 590006
- Exchange: BSE
- Founded: 1893
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: ₹12.082b
- Shares outstanding: 29.23m
- Website: https://www.amrutanjan.com
Number of Employees
- Amrutanjan Health Care Limited
- No.103 (Old No.42-45), Luz Church Road
- Tamil Nadu
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|590006||BSE (Mumbai Stock Exchange)||Yes||Equity Shares||IN||INR||May 2005|
|AMRUTANJAN||NSEI (National Stock Exchange of India)||Yes||Equity Shares||IN||INR||May 2005|
Amrutanjan Health Care Limited produces and sells ayurvedic pain balms in India. It operates through OTC products, Beverages, and Others segments. The company offers pain management products, including pai ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/10/29 12:46|
|End of Day Share Price||2020/10/29 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.